The Opportunity
$6.9 Trillion
The global wellness economy is one of the world’s largest and fastest-growing markets — and The Experiential sits at the intersection of its highest-growth sectors.
Source: Global Wellness Institute, 2024 · CAGR figures: 2019–2024 (past) & 2024–2029 (future)
Where the Growth Is
Wellness Economy by Sector
Across eleven sectors totaling $6.9 trillion, the wellness economy is accelerating — with several of TE’s core sectors leading the charge.
Explosive Growth Sectors
$548.4B
Wellness Real Estate
Past
19.5%
Future
15.2%
$268.3B
Mental Wellness
Past
12.4%
Future
10.1%
Mature & Steady Growth Sectors
$1,143.9B
Physical Activity
Past
4.6%
Future
5.1%
$1,350.0B
Personal Care & Beauty
Past
4.8%
Future
4.8%
$1,148.0B
Healthy Eating, Nutrition & Weight Loss
Past
4.7%
Future
7.1%
$605.6B
Traditional & Complementary Medicine
Past
4.6%
Future
10.8%
Tourism-Based Sectors
$893.9B
Wellness Tourism
Past
6.4%
Future
9.1%
$157.4B
Spas
Past
6.2%
Future
7.7%
$71.7B
Thermal / Mineral Springs
Past
1.7%
Future
10.0%
Public / Private Policy-Based Sectors
$675.9B
Public Health, Prevention & Personal Medicine
Past
8.6%
Future
4.7%
$53.3B
Workplace Wellness
Past
0.7%
Future
2.2%
Our Addressable Sectors
The Experiential operates at the intersection of four high-growth wellness sectors
$268.3B
Mental Wellness
10.1% CAGR
$893.9B
Wellness Tourism
9.1% CAGR
$605.6B
Traditional & Complementary Medicine
10.8% CAGR
$157.4B
Spas
7.7% CAGR
$1.93T
Combined addressable market across TE’s four core wellness sectors
The Unmet Need
Mental Wellness: The Largest Gap in a $6.9T Economy
Within the global wellness economy, mental health represents the most underserved category — a ~$5 trillion economic burden driven by treatments that consistently fail to deliver lasting results.
Source: Arias, Saxena & Verguet, The Lancet eClinicalMedicine (2022)
280M+
Depression
People globally affected
301M
Anxiety Disorders
Living with anxiety worldwide
35M
Substance Use Disorders
Struggling with addiction
1 in 5
Adults Affected
Experience mental illness annually
Traditional Treatment is Failing
Despite $280B spent annually on mental health in the US alone, outcomes remain poor. The system is designed for chronic management, not lasting healing — creating massive white space within the wellness economy.
of addicts relapse within the first year
of depression patients don't respond to medication
of PTSD patients show no improvement with CBT
~$5T
Economic Burden
Annual global cost of mental health disorders
$1T
Lost Productivity
Depression & anxiety alone (WHO)
$16T
Projected by 2030
Cumulative global impact
6.7%
Market Growth
Mental health services CAGR
Emerging Solution
Psychedelic-Assisted Therapy
Where traditional treatment fails, a new clinical paradigm is emerging within the wellness economy — backed by rigorous science, growing regulatory acceptance, and a rapidly expanding market.
Clinical Efficacy
- 67% remission rate for treatment-resistant depression (psilocybin)
- 83% reduction in PTSD symptoms (MDMA-assisted therapy)
- 60-80% addiction interruption rate (ibogaine)
Regulatory Progress
- FDA Breakthrough Therapy designation for psilocybin
- Australia approves MDMA and psilocybin prescribing
- Mexico permits ibogaine treatment
Market Growth
- $10.75B projected market by 2027
- 15%+ CAGR for psychedelic therapy sector
- $2.4B invested in psychedelic companies (2019-2023)
Target Customer
The UHNW Wellness Consumer
Our guests are already spending within the wellness economy. They have the means to seek the best care, the sophistication to understand the science, and the urgency that comes from failed conventional treatments.
Profile
High-functioning executives and entrepreneurs, ages 40–55, with $10M+ net worth — seeking transformation beyond what luxury rehab and traditional wellness retreats can offer.
Unit Economics
Average Treatment Program
All-inclusive programs
7-28 days
Revenue per Guest
Weighted average (13-day stay)
$26,600
Gross Margin per Guest
83% gross margin
$21,971
Customer Acquisition Cost
Blended CAC
$2,613
LTV:CAC Ratio
Strong unit economics
13.0x
Competitive Landscape
Where We Fit
Existing players address parts of the wellness economy, but none integrate medical-grade treatment, luxury hospitality, and emerging modalities into a single destination.
| Competitor Type | Examples | Strengths | Our Advantage |
|---|---|---|---|
| Luxury Rehab Centers | Promises, Passages Malibu | Brand recognition, insurance | Ibogaine efficacy, medical-grade protocols |
| Ayahuasca Retreats | Rhythmia, Soltara | Established, spiritual focus | Medical oversight, addiction specialization |
| Ibogaine Clinics | Beond, Clear Sky | Treatment expertise | Luxury experience, integration support |
| Bio-Optimization Centers | Bulletproof, Upgrade Labs | Wellness positioning | Combined modalities, deeper transformation |
Why Now?
The $6.9T wellness economy is accelerating, traditional mental health treatment is failing, and scientific breakthroughs are creating a once-in-a-generation convergence.
Science
Decades of research validating psychedelic-assisted therapy with 60-83% efficacy rates
Regulation
Global momentum toward legal access — Australia, Mexico, and FDA breakthrough designations
Demand
A $1.93T addressable market with failed conventional treatments driving consumers to seek alternatives